18/06/2026
😿貓腎衰竭 新AIM治療還要等到明年嗎？
全城貓主都在熱切期待 宮崎徹博士研發的AIM注射療法，希望能延緩貓貓腎衰竭的進程。但這項療法可能要到 2027 年才會正式推出。
在新藥推出之前，真的什麼都不能做嗎？
貓貓AIM的特性💡
貓貓體內的AIM同其他動物的不同之處，是貓貓的AIM被IgM抗體綁得太緊，不能自動釋放去清理血液中的廢物 ，慢慢形成腎衰竭。AIM注射藥可以直接引入不會被IgM抗體綁緊的AIM，去清理殘留物 ，大大減低腎衰竭形成危機。
🩺 基於AIM 的腎臟支持
是否有方法在未有新藥前, 可以將被IgM抗體綁緊的AIM釋放出去？
✅有！以及現在已經可以開始！根據 宮崎徹博士的研究，以特配高品質營養素作長期支持，現可以提前使用，幫助清除血液中的廢物，提供抗氧化支持，並提升細胞活力，以對抗並延緩貓貓腎衰竭的發展。此外，這些營養素支持也能與未來AIM 療法一同使用，為貓貓提供更全面的腎臟健康守護。我哋現在開始就可以為有需的貓貓服務，設定一個適合牠的醫療方案及進行跟進，歡迎過嚟同我哋醫生傾吓🧑🏻⚕️
有關更多AIM科研 https://greycoatresearch.com/aim-science
😿The Long Awaited Feline AIM Therapy
Cat owners across the city are eagerly awaiting Dr. Toru Miyazaki’s development of an AIM injection💉 to delay the progression of kidney failure in cats, but it may not be officially available until 2027. Does that mean nothing can be done before the drug is available?
The Characteristics of Feline AIM💡
What makes feline AIM different from that of other animals is that their AIM is bound too tightly by the antibody IgM, preventing it from being released to clear waste from the blood. Over time, this leads to kidney failure. The AIM injection works by directly introducing AIM that is not bound to IgM, helping to clear these residues and greatly delaying the progression of kidney failure.
🩺AIM-based Kidney Support
But is there any way to release the AIM from IgM before the new AIM injection therapy?
✅Yes—and it can start now! According to Dr. Toru Miyazaki’s research, specific high-quality long term nutritional support can be used in advance to help clear waste from the blood, provide antioxidant support, and boost cellular vitality to fight against and delay the development of kidney failure in cats, and it can also be used together with the future AIM therapy. Now, we are able to offer this support to cats in need, developing a suitable medical plan and providing follow-up care. Feel free to come and talk to us🧑🏻⚕️
More about AIM Science https://greycoatresearch.com/aim-science
